Serum adipokines in patients with psoriatic arthritis and psoriasis alone and their correlation with disease activity (Q43472253)

23 November 2017

Serum adipokines in patients with psoriatic arthritis and psoriasis alone and their correlation with disease activity (English)

1 reference

23 November 2017

1 reference

8

Dafna D Gladman

1 reference

23 November 2017

Lihi Eder

1

1 reference

23 November 2017

Jai Jayakar

2

1 reference

23 November 2017

Remy Pollock

3

1 reference

23 November 2017

Fawnda Pellett

4

1 reference

23 November 2017

Arane Thavaneswaran

5

1 reference

23 November 2017

Vinod Chandran

6

1 reference

23 November 2017

Cheryl F Rosen

7

1 reference

23 November 2017

language of work or name

English

0 references

publication date

14 December 2012

1 reference

Annals of the Rheumatic Diseases

23 November 2017

1 reference

23 November 2017

72

1 reference

23 November 2017

12

1 reference

23 November 2017

1956-1961

1 reference

Relationship of metabolic syndrome and fibrinolytic dysfunction to cardiovascular disease

23 November 2017

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2012-202325

Risks for all-cause mortality, cardiovascular disease, and diabetes associated with the metabolic syndrome: a summary of the evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2012-202325

Serum adiponectin, interleukin-10 levels and inflammatory markers in the metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2012-202325

Epidemiology of comorbidities in psoriasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2012-202325

Obesity, waist circumference, weight change, and the risk of psoriasis in women: Nurses' Health Study II.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2012-202325

Obesity and psoriasis: from the Medical Board of the National Psoriasis Foundation

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2012-202325

Evaluation of the atherogenic tendency of lipids and lipoprotein content and their relationships with oxidant-antioxidant system in patients with psoriasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2012-202325

Dislipidemia and oxidative stress in mild and in severe psoriasis as a risk for cardiovascular disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2012-202325

Cardiovascular comorbidities in patients with psoriatic arthritis: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2012-202325

Prevalence of atherosclerotic risk factors and the metabolic syndrome in patients with chronic inflammatory arthritis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2012-202325

The burden of carotid artery plaques is higher in patients with psoriatic arthritis compared with those with psoriasis alone

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2012-202325

Relationship of adiponectin to body fat distribution, insulin sensitivity and plasma lipoproteins: evidence for independent roles of age and sex.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2012-202325

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2012-202325

Leptin modulates the T-cell immune response and reverses starvation-induced immunosuppression

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2012-202325

Obesity in psoriasis: leptin and resistin as mediators of cutaneous inflammation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2012-202325

Incidence of arthritis in a prospective cohort of psoriasis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2012-202325

Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; Internat

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2012-202325

Cardiovascular risk profile of patients with psoriatic arthritis compared to controls--the role of inflammation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2012-202325

Obesity in early adulthood as a risk factor for psoriatic arthritis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2012-202325

Impact of body mass index and obesity on clinical response to systemic treatment for psoriasis. Evidence from the Psocare project.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2012-202325

The effect of weight on the efficacy of biologic therapy in patients with psoriasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2012-202325

Cardiovascular and other comorbidities in patients with psoriatic arthritis: a comparison with patients with psoriasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2012-202325

Obesity and risk of incident psoriatic arthritis in US women

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2012-202325

Adiponectin in health and diseases: from metabolic syndrome to tissue regeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2012-202325

Adiponectin: A novel adipokine linking adipocytes and vascular function

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2012-202325

The contribution of adipose tissue and adipokines to inflammation in joint diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2012-202325

Adipocytokines in systemic lupus erythematosus: relationship to inflammation, insulin resistance and coronary atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2012-202325

Association of circulating adiponectin levels with progression of radiographic joint destruction in rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2012-202325

Lack of effect of TNFalpha blockade therapy on circulating adiponectin levels in patients with autoimmune disease: results from two independent prospective studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2012-202325

Adiponectin relation to skin changes and dyslipidemia in systemic sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2012-202325

Baseline serum adipokine levels predict radiographic progression in early rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FANNRHEUMDIS-2012-202325

10.1136/ANNRHEUMDIS-2012-202325

21 January 2018

Identifiers

DOI

1 reference

release_7fdo3xv2q5hdrkh6jkw6wdji7a

23 November 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/7fdo3xv2q5hdrkh6jkw6wdji7a

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference